KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
82 hedge funds and large institutions have $117M invested in Kindred Biosciences, Inc. in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
34% less call options, than puts
Call options by funds: $158K | Put options by funds: $239K
Holders
82
Holding in Top 10
–
Calls
$158K
Puts
$239K
Top Buyers
| 1 | +$1.05M | |
| 2 | +$933K | |
| 3 | +$731K | |
| 4 |
BlackRock
New York
|
+$468K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$339K |
Top Sellers
| 1 | -$933K | |
| 2 | -$630K | |
| 3 | -$186K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$162K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$152K |